Sunshine Biopharma (SBFM) Short Interest Ratio & Short Volume → Warning: this could blow your mind (From DTI) (Ad) Free SBFM Stock Alerts $0.06 0.00 (0.00%) (As of 03/28/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Sunshine Biopharma Short Interest DataCurrent Short Volume971,000 sharesPrevious Short Volume445,300 sharesChange Vs. Previous Month+118.06%Dollar Volume Sold Short$58,260.00Short Interest Ratio / Days to Cover0.1Last Record DateMarch 15, 2024Outstanding Shares28,020,000 sharesFloat Size91,940,000 sharesShort Percent of Float1.06%Today's Trading Volume13,169,106 sharesAverage Trading Volume16,179,803 sharesToday's Volume Vs. Average81% Short Selling Sunshine Biopharma ? Sign up to receive the latest short interest report for Sunshine Biopharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatSBFM Short Interest Over TimeSBFM Days to Cover Over TimeSBFM Percentage of Float Shorted Over Time Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. Sunshine Biopharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/2024971,000 shares $58,260.00 +118.1%1.1%0.1 $0.06 2/29/2024445,300 shares $24,669.62 -26.1%1.0%0 $0.06 2/15/2024602,600 shares $38,265.10 +487.3%1.3%0.3 $0.06 1/31/2024102,600 shares $26,265.60 -9.1%0.4%0.5 $0.26 1/15/2024112,900 shares $28,642.73 -1.6%0.5%0.7 $0.25 12/31/2023114,700 shares $31,141.05 +90.5%0.5%0.7 $0.27 Get the Latest News and Ratings for SBFM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sunshine Biopharma and its competitors with MarketBeat's FREE daily newsletter. 12/15/202360,200 shares $14,327.60 -18.9%0.3%0.4 $0.24 11/30/202374,200 shares $21,443.80 -22.4%0.3%0.5 $0.29 11/15/202395,600 shares $26,194.40 -29.2%0.4%0.7 $0.27 10/31/2023135,100 shares $40,421.92 -35.0%0.6%0.9 $0.30 10/15/2023207,700 shares $66,443.23 +8.6%1.0%1.3 $0.32 9/30/2023191,200 shares $61,184.00 +3.4%0.9%1.1 $0.32 9/15/2023184,900 shares $73,368.32 -34.3%0.9%1.1 $0.40 8/31/2023281,200 shares $120,606.68 -52.5%1.3%1.5 $0.43 8/15/2023591,900 shares $307,788.00 +701.0%2.8%2.7 $0.52 7/31/202373,900 shares $37,689.00 -52.7%0.4%0.1 $0.51 7/15/2023156,300 shares $75,070.89 -32.2%0.9%0.1 $0.48 6/30/2023230,500 shares $113,982.25 -28.9%1.3%0.2 $0.49 6/15/2023324,000 shares $179,755.20 -39.9%1.8%0.2 $0.55 5/31/2023538,800 shares $328,668.00 -67.5%3.0%0.4 $0.61 5/15/20231,660,000 shares $1.05 million +525.9%9.2%1.3 $0.63 4/30/2023265,200 shares $165,935.64 -6.1%1.5%2.1 $0.63 4/15/2023282,500 shares $192,100.00 +28.1%1.5%1.9 $0.68 3/31/2023220,600 shares $161,214.48 -27.7%1.2%1.1 $0.73 3/15/2023305,300 shares $242,835.62 -13.8%1.7%1.4 $0.80 2/28/2023354,100 shares $319,079.51 -16.9%1.9%1.6 $0.90 2/15/2023426,000 shares $415,137.00 +7.6%2.3%1.9 $0.97 1/31/2023395,800 shares $486,834.00 +28.6%2.1%1.1 $1.23 1/15/2023307,900 shares $253,309.33 -19.4%1.7%0.8 $0.82 12/30/2022381,900 shares $244,416.00 -15.2%2.1%0.7 $0.64 12/15/2022450,400 shares $307,262.88 -5.8%2.5%0.9 $0.68 11/30/2022478,300 shares $378,383.13 +14.0%2.9%0.8 $0.79 11/15/2022419,600 shares $351,163.24 -21.9%2.5%0.7 $0.84 10/31/2022537,200 shares $459,467.16 +1,239.7%3.2%1.1 $0.86 10/15/202240,100 shares $32,280.50 -46.5%0.3%0 $0.81 9/30/202275,000 shares $57,937.50 -30.7%0.5%0.1 $0.77 9/15/2022108,200 shares $105,094.66 -72.7%0.7%0.1 $0.97 8/31/2022396,100 shares $435,710.00 -32.9%2.5%0.4 $1.10 8/15/2022590,700 shares $773,817.00 +20.2%3.7%0.4 $1.31 7/31/2022491,600 shares $530,928.00 +641.5%3.1%0.3 $1.08the most reliable asset on earth is making a comeback (Ad)Global tensions have been pushing the price of gold to all time highs… Just recently, gold peaked at a record $2,000 (and is now closer to $2,200). And there’s something else critical at play right now in the world’s largest asset. Because of these critical factors, a lot of massive investment institutions are now pumping more money into gold. And as we speak, some are even calling for a massive rally in the precious metal.And you can see how it works for FREE when you Click Here SBFM Short Interest - Frequently Asked Questions What is Sunshine Biopharma's current short interest? Short interest is the volume of Sunshine Biopharma shares that have been sold short but have not yet been closed out or covered. As of March 15th, traders have sold 971,000 shares of SBFM short. 1.06% of Sunshine Biopharma's shares are currently sold short. Learn More on Sunshine Biopharma's current short interest. What is a good short interest percentage for Sunshine Biopharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.06% of Sunshine Biopharma's floating shares are currently sold short. Is Sunshine Biopharma's short interest increasing or decreasing? Sunshine Biopharma saw a increase in short interest in March. As of March 15th, there was short interest totaling 971,000 shares, an increase of 118.1% from the previous total of 445,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Sunshine Biopharma's float size? Sunshine Biopharma currently has issued a total of 28,020,000 shares. Some of Sunshine Biopharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Sunshine Biopharma currently has a public float of 91,940,000 shares. How does Sunshine Biopharma's short interest compare to its competitors? 1.06% of Sunshine Biopharma's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Sunshine Biopharma: Cyclacel Pharmaceuticals, Inc. (2.22%), Histogen Inc. (1.87%), 60 Degrees Pharmaceuticals, Inc. (1.46%), Dermata Therapeutics, Inc. (2.05%), Phio Pharmaceuticals Corp. (7.36%), NeuBase Therapeutics, Inc. (2.66%), Allarity Therapeutics, Inc. (11.75%), Clearmind Medicine Inc. (3.17%), Salarius Pharmaceuticals, Inc. (0.36%), Baudax Bio, Inc. (1.11%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Cummins Inc. ($8.93 billion), Canadian Natural Resources Limited ($7.79 billion), Super Micro Computer, Inc. ($4.31 billion), T-Mobile US, Inc. ($4.00 billion), General Motors ($3.36 billion), Occidental Petroleum Co. ($3.10 billion), Charter Communications, Inc. ($2.92 billion), Coinbase Global, Inc. ($2.74 billion), Tractor Supply ($2.72 billion), and Moderna, Inc. ($2.31 billion). View all of the most shorted stocks. What does it mean to sell short Sunshine Biopharma stock? Short selling SBFM is an investing strategy that aims to generate trading profit from Sunshine Biopharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Sunshine Biopharma? A short squeeze for Sunshine Biopharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SBFM, which in turn drives the price of the stock up even further. How often is Sunshine Biopharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SBFM, twice per month. The most recent reporting period available is March, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Cyclacel Pharmaceuticals Short Interest Data Histogen Short Interest Data 60 Degrees Pharmaceuticals Short Interest Data Dermata Therapeutics Short Interest Data Phio Pharmaceuticals Short Interest Data NeuBase Therapeutics Short Interest Data Allarity Therapeutics Short Interest Data Clearmind Medicine Short Interest Data Salarius Pharmaceuticals Short Interest Data Baudax Bio Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SBFM) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 Media“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyFed launches fourth dollar overhaulStansberry ResearchAI healthcare stock poised for 36,996% growth?Behind the Markets